Clinical Trials Browser

Withdrawn × ceritinib × Clear all

NCT02729961 2019-10-10

Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Large-Cell, Anaplastic

NCT02289144 2019-07-30

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Phase 2 Withdrawn

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT02343679 2017-02-01

Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies

Phase 2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms